IGF1 and type 2 diabetes mellitus: Endothelin-1, its membrane receptor and IGF1 gene expressions were significantly upregulated by T2D, leading to a predicting activation of concentric hypertrophic cardiomyopathy pathways (Fig. 4, point A).